Abstract
Due to a wide range of clinical response in patients undergoing neo-adjuvant chemoradiation for rectal cancer it is essential to understand molecular factors that lead to the broad response observed in patients receiving the same form of treatment. Despite extensive research in this field, the exact mechanisms still remain elusive. Data raging from DNA-repair to specific molecules leading to cell survival as well as resistance to apoptosis have been investigated. Individually, or in combination, there is no single pathway that has become clinically applicable to date. In the following review, we describe the current status of various pathways that might lead to resistance to the therapeutic applications of ionizing radiation in rectal cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 194-210 |
Number of pages | 17 |
Journal | World Journal of Gastrointestinal Oncology |
Volume | 6 |
Issue number | 7 |
DOIs | |
State | Published - Jul 15 2014 |
Keywords
- Angiogenesis
- Apoptosis
- Complete pathological response
- DNA double-strand break
- DNA-PKcs
- Ionizing radiation
- Ku proteins
- Non-homologous end-joining pathway
- Radiation therapy
ASJC Scopus subject areas
- Oncology
- Gastroenterology